Apr 02, 2026
Our Approach To Quality And Reliability in APIs, Intermediates And Excipients Supply
At Hangzhou Jeci Biochem Technology Co., Ltd., we understand that when it comes to pharmaceutical ingredients, quality is never negotiable.
-
![Notice Regarding National Day Holiday Arrangements For 2025]()
Sep 26, 2025Notice Regarding National Day Holiday Arrangements For 2025Dear Valued Customer, Greetings! On the occasion of the upcoming National Day holiday, the entire team at HANGZHOU JECI extends our warmest holiday...view more -
![Gilead Expands Cell Therapy Footprint With $350M Cash Acquisition Of Interi...]()
Sep 25, 2025Gilead Expands Cell Therapy Footprint With $350M Cash Acquisition Of Interi...Cell therapy, as an innovative frontier in biopharma, is advancing at a remarkable pace. While traditional CAR-T therapies have achieved groundb...view more -
![Soaring 161%! The Invisible Winner in The MASH Race Steps Into The Spotlight]()
Sep 25, 2025Soaring 161%! The Invisible Winner in The MASH Race Steps Into The SpotlightFrom Traditional Chinese Medicine to Global Leader in Liver Disease Diagnostics In March 2024, the first-ever MASH (metabolic dysfunction-assoc...view more -
![ESMO Highlight: Domestic Radiopharmaceutical Selected As LBA]()
Sep 25, 2025ESMO Highlight: Domestic Radiopharmaceutical Selected As LBAThe 2025 European Society for Medical Oncology (ESMO) Annual Meeting will be held from October 17–21 in Berlin, Germany. As one of the m...view more -
![HANGZHOU JECI: The Leading HMDS Sales Champion In Pharmaceutical Chemical For...]()
Sep 18, 2025HANGZHOU JECI: The Leading HMDS Sales Champion In Pharmaceutical Chemical For...In the global pharmaceutical chemical industry landscape, hexamethyldisilazane (HMDS) has become a pivotal raw material in drug research and produc...view more -
![Have Small-Molecule Weight-Loss Drugs Reached A Dead End?]()
Sep 15, 2025Have Small-Molecule Weight-Loss Drugs Reached A Dead End?GLP-1 receptor agonists have garnered widespread attention due to their remarkable weight-loss and diabetes-treatment effects. However, despite the...view more -
![Nanjing Tech University Achieves High-Yield Ectoine Production By E. Coli U...]()
Sep 09, 2025Nanjing Tech University Achieves High-Yield Ectoine Production By E. Coli U...Ectoine ( 1,4,5,6-tetrahydro-2-methyl-4-pyrimidinecarboxylic acid , CAS: 96702-03-3 ), a natural protective molecule, exhibits an exceptional ...view more -
![Aikang Biopharma’s Breakthrough First: Driving The 'Gold Rush' Of PD-1/VEGF ...]()
Sep 08, 2025Aikang Biopharma’s Breakthrough First: Driving The 'Gold Rush' Of PD-1/VEGF ...Aikang Biopharma's Breakthrough First Introduction: Sparking the "Gold Rush" of PD-1/VEGF Bispecific Antibodies In the evolution of immuno-onc...view more -
![€3.8 Billion Bet: Servier Acquires Global Rights (Ex-US) To PKC Inhibitor D...]()
Sep 05, 2025€3.8 Billion Bet: Servier Acquires Global Rights (Ex-US) To PKC Inhibitor D...Introduction: Servier secures worldwide (excluding the US) rights to the PKC inhibitor darovasertib in a major deal.view more -
![Over $5 Billion Deal: MNCs Snap Up Domestic Innovative Drugs Again]()
Sep 05, 2025Over $5 Billion Deal: MNCs Snap Up Domestic Innovative Drugs AgainIntroduction: Involving Multiple Cardiovascular siRNA Therapeuticsview more -
![Pfizer’s Key Drug For Sickle Cell Disease, Inclacumab, Fails To Meet Primary ...]()
Aug 21, 2025Pfizer’s Key Drug For Sickle Cell Disease, Inclacumab, Fails To Meet Primary ...Recently, Pfizer announced that its investigational key drug for sickle cell disease (SCD), inclacumab, failed to meet the primary endpoint in the ...view more -
![Oral TXA Doesn’t Darken Or Lighten Hair: Study]()
Aug 19, 2025Oral TXA Doesn’t Darken Or Lighten Hair: StudyTranexamic acid (TXA) is widely used to treat melasma, but its potential effects on hair pigmentation have remained unexplored. Concerns about hair...view more
